TotalMarketCap

Eloxx Pharmaceuticals

ELOXNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$52.050 M

$12.90 +1.22%

Close of 6 Nov 2026

As of 6 Nov 2026, Eloxx Pharmaceuticals (ELOX) has a market capitalization of $52.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$6.00M

Loss-making

Shares outstanding

4,036,459

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #121Cardiff OncologyCRDF$58.9M
  2. #122Kalaris TherapeuticsKLRS$55.9M
  3. #123Eloxx PharmaceuticalsELOX$52.1M
  4. #124MiNK TherapeuticsINKT$50.7M
  5. #125Greenland MinesGRML$49.3M

What if Eloxx Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$6,995,457

Per share 542,494× higher

Bitcoin $1.53T

$378,511.98

Per share 29,353× higher

Apple $5.02T

$1,242,619

Per share 96,364× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Eloxx Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.